Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:clinical_trial |
NC T02929833
NC T02929846 NC T02929859 NC T02929872 NC T02929885 |
| gptkbp:dosage_form |
3000 units
|
| gptkbp:effective_date |
2017-10-20
|
| gptkbp:form |
gptkb:software_framework
|
| https://www.w3.org/2000/01/rdf-schema#label |
Haegarda
|
| gptkbp:indication |
prophylaxis of angioedema attacks
|
| gptkbp:ingredients |
gptkb:C1_esterase_inhibitor
|
| gptkbp:is_used_for |
gptkb:hereditary_angioedema
|
| gptkbp:manager |
subcutaneous
|
| gptkbp:manufacturer |
gptkb:CSL_Behring
|
| gptkbp:side_effect |
fatigue
headache nausea injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:bfsParent |
gptkb:Cinryze
|
| gptkbp:bfsLayer |
5
|